Literature DB >> 19366913

Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock.

Ineke Vanlaere1, Claude Libert.   

Abstract

The mammalian immune system is optimized to cope effectively with the constant threat of pathogens. However, when the immune system overreacts, sepsis, severe sepsis, or septic shock can develop. Despite extensive research, these conditions remain the leading cause of death in intensive care units. The matrix metalloproteinases (MMPs) constitute a family of proteases that are expressed in developmental, physiological, and pathological processes and also in response to infections. Studies using MMP inhibitors and MMP knockout mice indicate that MMPs play essential roles in infection and in the host defense against infection. This review provides a brief introduction to some basic concepts of infections caused by gram-negative bacteria and reviews reports describing MMP expression and inhibition, as well as studies with MMP-deficient mice in models of infection caused by gram-negative bacteria and of septic shock. We discuss whether MMPs should be considered novel drug targets in infection and septic shock.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19366913      PMCID: PMC2668236          DOI: 10.1128/CMR.00047-08

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  160 in total

Review 1.  Extracellular matrix remodelling: the role of matrix metalloproteinases.

Authors:  Ivan Stamenkovic
Journal:  J Pathol       Date:  2003-07       Impact factor: 7.996

2.  MAP kinase activation is required for the MMP-9 induction by TNF-stimulation.

Authors:  Kyung Chan Kim; Chu Hee Lee
Journal:  Arch Pharm Res       Date:  2005-11       Impact factor: 4.946

Review 3.  Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases.

Authors:  Jialiang Hu; Philippe E Van den Steen; Qing-Xiang A Sang; Ghislain Opdenakker
Journal:  Nat Rev Drug Discov       Date:  2007-06       Impact factor: 84.694

4.  Activation of human matrix metalloproteinases by various bacterial proteinases.

Authors:  T Okamoto; T Akaike; M Suga; S Tanase; H Horie; S Miyajima; M Ando; Y Ichinose; H Maeda
Journal:  J Biol Chem       Date:  1997-02-28       Impact factor: 5.157

5.  LPS challenge in D-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock.

Authors:  A Mignon; N Rouquet; M Fabre; S Martin; J C Pagès; J F Dhainaut; A Kahn; P Briand; V Joulin
Journal:  Am J Respir Crit Care Med       Date:  1999-04       Impact factor: 21.405

6.  Neutrophil emigration in the lungs, peritoneum, and skin does not require gelatinase B.

Authors:  T Betsuyaku; J M Shipley; Z Liu; R M Senior
Journal:  Am J Respir Cell Mol Biol       Date:  1999-06       Impact factor: 6.914

7.  Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4.

Authors:  S T Smiley; J A King; W W Hancock
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

8.  The role of neutrophil collagenase in endotoxic acute lung injury.

Authors:  Tao Xu; Bangxiong Zeng; Xingwang Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

9.  Matrix metalloproteinase-2 (MMP-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP-ribose) polymerase (PARP) in vitro.

Authors:  Jennifer A Kwan; Costas J Schulze; Wenjie Wang; Hernando Leon; Meltem Sariahmetoglu; Miranda Sung; Jolanta Sawicka; David E Sims; Grzegorz Sawicki; Richard Schulz
Journal:  FASEB J       Date:  2004-02-06       Impact factor: 5.191

10.  Gelatinase B modulates selective opening of the blood-brain barrier during inflammation.

Authors:  S Mun-Bryce; G A Rosenberg
Journal:  Am J Physiol       Date:  1998-05
View more
  52 in total

1.  Pro-inflammatory effects of matrix metalloproteinase 7 in acute inflammation.

Authors:  R E Vandenbroucke; I Vanlaere; F Van Hauwermeiren; E Van Wonterghem; C Wilson; C Libert
Journal:  Mucosal Immunol       Date:  2013-10-16       Impact factor: 7.313

2.  Matrix metalloproteinase-19 promotes metastatic behavior in vitro and is associated with increased mortality in non-small cell lung cancer.

Authors:  Guoying Yu; Jose D Herazo-Maya; Tomoko Nukui; Marjorie Romkes; Anil Parwani; Brenda M Juan-Guardela; Jennifer Robertson; Jack Gauldie; Jill M Siegfried; Naftali Kaminski; Daniel J Kass
Journal:  Am J Respir Crit Care Med       Date:  2014-10-01       Impact factor: 21.405

3.  Antimicrobial activity of a halocidin-derived peptide resistant to attacks by proteases.

Authors:  Yong Pyo Shin; Ho Jin Park; Seo Hwa Shin; Young Shin Lee; Seungmi Park; Sungho Jo; Yong Ho Lee; In Hee Lee
Journal:  Antimicrob Agents Chemother       Date:  2010-04-12       Impact factor: 5.191

4.  Featured Article: Nanoenhanced matrix metalloproteinase-responsive delivery vehicles for disease resolution and imaging.

Authors:  Donald A McCarthy; Ahmad A Nazem; James McNeilan; Nicole L Shakerley; Ryan R Clark; María D Idelchik; Mehmet Yigit; J Andrés Melendez
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-29

Review 5.  Ras-oncogenic Drosophila hindgut but not midgut cells use an inflammation-like program to disseminate to distant sites.

Authors:  Theodoulakis Christofi; Yiorgos Apidianakis
Journal:  Gut Microbes       Date:  2012-10-12

6.  Pleural fluid analysis of lung cancer vs benign inflammatory disease patients.

Authors:  R Kremer; L A Best; D Savulescu; M Gavish; R M Nagler
Journal:  Br J Cancer       Date:  2010-03-09       Impact factor: 7.640

Review 7.  Gene expression profiling in sepsis: timing, tissue, and translational considerations.

Authors:  David M Maslove; Hector R Wong
Journal:  Trends Mol Med       Date:  2014-02-15       Impact factor: 11.951

8.  Interaction of Leptospira interrogans with human proteolytic systems enhances dissemination through endothelial cells and protease levels.

Authors:  Monica L Vieira; Miryam P Alvarez-Flores; Karin Kirchgatter; Eliete C Romero; Ivy J Alves; Zenaide M de Morais; Silvio A Vasconcellos; Ana M Chudzinski-Tavassi; Ana L T O Nascimento
Journal:  Infect Immun       Date:  2013-03-11       Impact factor: 3.441

9.  Matrix metalloprotease 1a deficiency suppresses tumor growth and angiogenesis.

Authors:  C J Foley; M Fanjul-Fernández; A Bohm; N Nguyen; A Agarwal; K Austin; G Koukos; L Covic; C López-Otín; A Kuliopulos
Journal:  Oncogene       Date:  2013-05-27       Impact factor: 9.867

10.  Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis.

Authors:  Leonardo Lorente; María M Martín; Lorenzo Labarta; César Díaz; Jordi Solé-Violán; José Blanquer; Josune Orbe; José A Rodríguez; Alejandro Jiménez; Juan M Borreguero-León; Felipe Belmonte; Juan C Medina; Maria C Llimiñana; José M Ferrer-Agüero; José Ferreres; María L Mora; Santiago Lubillo; Manuel Sánchez; Ysamar Barrios; Antonio Sierra; José A Páramo
Journal:  Crit Care       Date:  2009-10-02       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.